Alto Neuroscience, Inc. (ANRO) Tops Q3 EPS by 12c

Alto Neuroscience, Inc. (NYSE: ANRO) reported Q3 EPS of ($0.52), $0.12 better than the analyst estimate of ($0.64).

For earnings history and earnings-related data on Alto Neuroscience, Inc. (ANRO) click here.

You May Also Be Interested In

• Bernstein SocGen Group Upgrades X-Fab Silicon Foundries SE (XFAB:FP) to Outperform
• Barclays Reiterates Overweight Rating on Tele2 AB (TEL2B:SS) (TLTZY)
• UBS Starts Compass Gas e Energia SA (PASS3:BZ) at Buy